4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and troglitazone

4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with troglitazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, GG; Hsin, MK; Li, MY; Mok, TS; Underwood, MJ; Yip, J	1

Other Studies

1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and troglitazone

Article	Year
PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation. American journal of respiratory cell and molecular biology, 2010, Volume: 42, Issue:1 Topics: Carcinogens; Cell Line, Tumor; Cell Proliferation; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Heme Oxygenase-1; Humans; Lung; Lung Neoplasms; NF-kappa B; Nitrosamines; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Smoking; Thiazolidinediones; Transcription, Genetic; Troglitazone	2010

Article

Year

PPARgamma activation extinguishes smoking carcinogen by inhibiting NNK-mediated proliferation.

American journal of respiratory cell and molecular biology, 2010, Volume: 42, Issue:1

Topics: Carcinogens; Cell Line, Tumor; Cell Proliferation; Chromans; Cyclin-Dependent Kinase Inhibitor p21; Heme Oxygenase-1; Humans; Lung; Lung Neoplasms; NF-kappa B; Nitrosamines; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Smoking; Thiazolidinediones; Transcription, Genetic; Troglitazone

2010